Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Akebia Therapeutics, Inc. (AKBA)

« Back to company index

AKBA Chatter Timeline

Stock Ticker for AKBA

Most Active Tweeters for AKBA

UserTweets
@whatsonthorold2 4
@portefeuillefun 3
@reurope_stock 3
@bibeypost_stock 3
@fascination_bio 2

Recent Tweets for AKBA

bibeypost_stock @bibeypost_stock
Akebia Therapeutics Inc $AKBA Shorts Decreased by 1.36% After Short Covering - https://t.co/jaIEmK92Sw
July 17th 2018, 4:07pm
reurope_stock @reurope_stock
What Next for Akebia Therapeutics Inc $AKBA Stock After Decrease in Shorted Shares? https://t.co/Z4WSsHnwZG
July 17th 2018, 4:07pm
mmahotstuff1 @mmahotstuff1
Does Akebia Therapeutics Inc $AKBA Have Gas After Even Less Sellers Involved? - https://t.co/0s3n70wCzl
July 17th 2018, 4:07pm
whatsonthorold2 @whatsonthorold2
Akebia Therapeutics Inc $AKBA Reports Decline in Sellers; Strong Momentum for Longs - https://t.co/3L6rCHE3zZ
July 17th 2018, 4:07pm
portefeuillefun @portefeuillefun
Sold 1000 $AKBA at $10.37, now 1500 #vssporte shares.
July 17th 2018, 9:07am
dakotafinancial @dakotafinancial
Akebia Therapeutics Inc $AKBA to Post FY2018 Earnings of -$1.46 Per Share, Piper Jaffray Companies Forecasts https://t.co/w8Pseo7t3J
July 17th 2018, 2:07am
ledgerzette @ledgerzette
Akebia Therapeutics Inc $AKBA to Post FY2018 Earnings of -$1.46 Per Share, Piper Jaffray Companies Forecasts https://t.co/ewr6bpYvQm
July 17th 2018, 2:07am
ThisLincolnian @ThisLincolnian
FY2018 EPS Estimates for Akebia Therapeutics Inc Increased by Piper Jaffray Companies $AKBA https://t.co/TAsADePot1
July 16th 2018, 2:07am
fascination_bio @fascination_bio
@ResearchBiotech fresenius is not the only dialysis provider as you well know. in any event, does $akba remain a sl… https://t.co/OfOqQp6BOJ
July 14th 2018, 4:07am
whatsonthorold2 @whatsonthorold2
Analysts See $-0.51 EPS for Akebia Therapeutics, Inc. $AKBA - https://t.co/hrqyPWhveZ
July 14th 2018, 3:07am
ResearchBiotech @ResearchBiotech
@fascination_bio We're 2 years away from having to sell anything. $AKBA paid 50% of market cap (most of which was… https://t.co/r784fqem87
July 14th 2018, 3:07am
fascination_bio @fascination_bio
@ResearchBiotech Umm in the post approval real world, drugs need a sales force to sell right? $akba gets to leverag… https://t.co/YjEJZhBr5N
July 14th 2018, 2:07am
AviseAnalytics @AviseAnalytics
RT @reurope_stock: Is Major Move Coming For Akebia Therapeutics, Inc. $AKBA After This Bearish Multiple Bottom Chart Pattern? https://t.co/…
July 13th 2018, 6:07am
bibeypost_stock @bibeypost_stock
Is Selling Akebia Therapeutics, Inc. $AKBA Here a Winning Strategy? The Stock Formed Bearish Multiple Bottom Patter… https://t.co/Xax1hZLCjG
July 13th 2018, 6:07am
reurope_stock @reurope_stock
Is Major Move Coming For Akebia Therapeutics, Inc. $AKBA After This Bearish Multiple Bottom Chart Pattern? https://t.co/BRTmgmQ1vS
July 13th 2018, 6:07am
mmahotstuff1 @mmahotstuff1
Akebia Therapeutics, Inc. $AKBA's Trend Down, Especially After Forming a Bearish Multiple Bottom Chart Pattern - https://t.co/ArEN5twoTp
July 13th 2018, 6:07am
whatsonthorold2 @whatsonthorold2
Could Akebia Therapeutics, Inc. $AKBA Change Direction After This Multiple Bottom - https://t.co/7rA7MJOcmy
July 13th 2018, 6:07am
filing_scanner @filing_scanner
$AKBA New Insider Filing On: Butler John P. Transaction Code: M https://t.co/0P59UuJmfn
July 12th 2018, 11:07pm
tuduylinh @tuduylinh
@vlad33301 $akba 100Ksh @47c = 47K$, no quite chump change but nothing to write home to Mom abt lol . imo quite com… https://t.co/ys6lpHUEP8
July 12th 2018, 8:07pm
vlad33301 @vlad33301
$AKBA CEO exercises option to buy 100K shares https://t.co/RTdastXkEe
July 12th 2018, 7:07pm
InsiderAlertsIA @InsiderAlertsIA
$AKBA: New Insider Filing on CEO and President JOHN P. BUTLER: https://t.co/7DTliRG3ra
July 12th 2018, 5:07pm
confcalltran @confcalltran
Akebia Therapeutics, Inc. insider just picked up 100,000 shares https://t.co/gvlGE2KhhD $AKBA
July 12th 2018, 5:07pm
livetraderalrt @livetraderalrt
$AKBA 0.9m ago: Insider Butler John P. (CEO and President) added 100,000 (19.6%) shares at $0.47/share (Exercise/Co… https://t.co/MT9btX335c
July 12th 2018, 5:07pm
zipjet @zipjet
RT @Biomaven: I'd add also that you can only show this effect by comparison to placebo in NDD trials. The competitors $AKBA and $GSK are no…
July 12th 2018, 1:07pm
Biomaven @Biomaven
I'd add also that you can only show this effect by comparison to placebo in NDD trials. The competitors $AKBA and… https://t.co/8TVIvHrxsx
July 12th 2018, 12:07pm
The_CasualSmart @The_CasualSmart
Institutional Investors Lead Shift in Akebia Therapeutics $AKBA Sentiment https://t.co/EVbEJ0bqMh
July 12th 2018, 8:07am
portefeuillefun @portefeuillefun
RT @odibro: $AKBA Reiterated with an overweight at Piper. $22 PT
July 12th 2018, 5:07am
odibro @odibro
$AKBA Reiterated with an overweight at Piper. $22 PT
July 12th 2018, 5:07am
WatchlistN @WatchlistN
Akebia Therapeutics Inc $AKBA Expected to Announce Quarterly Sales of $48.75 Million https://t.co/iJgcb9njWK
July 11th 2018, 11:07am
TickerReport @TickerReport
$48.75 Million in Sales Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/axWKHX6QHo
July 11th 2018, 11:07am
dhovekamp42 @dhovekamp42
RT @vlad33301: $AKBA updated merger slide deck https://t.co/ZlfRioJkfS
July 11th 2018, 10:07am
vlad33301 @vlad33301
$AKBA updated merger slide deck https://t.co/ZlfRioJkfS
July 11th 2018, 9:07am
confcalltran @confcalltran
Prospectuses and communications, business combinations https://t.co/QJFOi8KwFz $AKBA
July 11th 2018, 8:07am
portefeuillefun @portefeuillefun
@bio_clouseau In case you are asking yourself "#Otsuka, where have I come across that name before?" -> https://t.co/mm5Zocs7Mp. $VIST $AKBA
July 11th 2018, 7:07am
MarkSzuch @MarkSzuch
$AKBA: Top Line results to start coming out of its pipeline in 2019. Looks like a number of indications across a s… https://t.co/yLQ4TNRLNf
July 10th 2018, 9:07am
MareaInformativ @MareaInformativ
-$0.52 EPS Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/sE3DSYX2jo
July 9th 2018, 6:07am
TranscriptDaily @TranscriptDaily
Zacks: Brokerages Expect Akebia Therapeutics Inc $AKBA to Post -$0.52 Earnings Per Share https://t.co/ebFNsKncVH
July 9th 2018, 5:07am
bibeypost_stock @bibeypost_stock
What Will Happen to Akebia Therapeutics, Inc. $AKBA Next? The Stock Formed a Several Months Multiple Bottom Pattern… https://t.co/5wohCzjozk
July 8th 2018, 6:07am
reurope_stock @reurope_stock
Akebia Therapeutics, Inc. $AKBA Could Burn Your Portfolio. The Stock Formed Bearish Multiple Bottom Chart Pattern https://t.co/GY9GEia5BL
July 8th 2018, 6:07am
whatsonthorold2 @whatsonthorold2
Is Major Move Coming For Akebia Therapeutics, Inc. $AKBA After This Bearish Multiple Bottom Pattern? - https://t.co/KgkKe57WoO
July 8th 2018, 6:07am
MareaInformativ @MareaInformativ
Zacks: Analysts Anticipate Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $48.75 Million https://t.co/lomjB1srj5
July 8th 2018, 6:07am
ThisLincolnian @ThisLincolnian
Zacks: Brokerages Expect Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $48.75 Million https://t.co/lGR85B0y2q
July 8th 2018, 1:07am
WeekHerald @WeekHerald
Zacks: Analysts Anticipate Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $48.75 Million https://t.co/V90TsWedWS
July 8th 2018, 1:07am
AmericanBanking @AmericanBanking
Zacks: Analysts Anticipate Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $48.75 Million https://t.co/XQecDpe9eN #stocks
July 8th 2018, 1:07am
EnterpriseLeade @EnterpriseLeade
ValuEngine Downgrades Akebia Therapeutics $AKBA to Sell https://t.co/XY47X2nFqa
July 7th 2018, 7:07am
AmericanBanking @AmericanBanking
-$0.52 Earnings Per Share Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/IDhq0DpEP8 #stocks
July 6th 2018, 8:07pm
ConsumerFeed @ConsumerFeed
-$0.52 Earnings Per Share Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/fhvQoi5QbT
July 6th 2018, 8:07pm
ConsumerFeed @ConsumerFeed
Akebia Therapeutics $AKBA Downgraded by ValuEngine to “Sell” https://t.co/BoTs57SGg4
July 5th 2018, 7:07am
OlympiaReport @OlympiaReport
Akebia Therapeutics Inc to Post FY2022 Earnings of $2.35 Per Share, Piper Jaffray Companies Forecasts $AKBA https://t.co/KTHXsOwknI
July 4th 2018, 2:07am
dispatchtribune @dispatchtribune
Akebia Therapeutics Inc to Post FY2022 Earnings of $2.35 Per Share, Piper Jaffray Companies Forecasts $AKBA https://t.co/fCgFS7qP3Q
July 4th 2018, 2:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.